About
Lab Reagents, Antibodies
Areas of Focus
Categories
Non-PharmaceuticalAntibodyBoston & New England
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
3
As Collaborator
3
Total Enrollment
247
By Phase
PHASE3: 1PHASE2/PHASE3: 2PHASE1: 2PHASE2: 1
By Status
COMPLETED: 5TERMINATED: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06037408Lead Sponsor
The Effect of N115 on Coughing in IPF Patients
PHASE3Completed
50 participants
Started: Aug 15, 2023 · Completed: May 20, 2024
NCT04871815Lead Sponsor
Effects of Sodium Pyruvate Nasal Spray in COVID-19 Long Haulers.
PHASE2/PHASE3Completed
22 participants
Started: Apr 27, 2021 · Completed: Mar 7, 2022
NCT04824365Lead Sponsor
Sodium Pyruvate Nasal Spray Treatment of COVID-19 Infection
PHASE2/PHASE3Completed
30 participants
Started: Apr 12, 2021 · Completed: Aug 12, 2022
NCT00308243Collaborator
Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis.
PHASE1Completed
15 participants
Started: Mar 31, 2006 · Completed: Mar 31, 2007
NCT00332215Collaborator
A Phase I Study of Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis.
PHASE1Terminated
70 participants
Started: Feb 28, 2006
Locations (1)
Headquarters
Newburyport, MA, United States
Map
Loading map...